Bajaj Healthcare Ltd.
BSE: 539872 | Sector: Health care |
NSE: BAJAJHCARE | ISIN Code: INE411U01027 |
BSE 00:00 | 26 May | 309.90 |
-9.85 (-3.08%) |
OPEN
316.30 |
HIGH
321.15 |
LOW
300.25 |
NSE 00:00 | 26 May | 310.20 |
-9.10 (-2.85%) |
OPEN
312.00 |
HIGH
321.00 |
LOW
300.15 |
OPEN | 316.30 |
PREVIOUS CLOSE | 319.75 |
VOLUME | 7111 |
52-Week high | |
52-Week low | |
P/E | 11.98 |
Mkt Cap.(Rs cr) | 855 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bajaj Healthcare Ltd. (BAJAJHCARE) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 535.50 | 12.35 | 2.36 | 15823.68 |
Cipla | 964.40 | -6.95 | -0.72 | 13900.58 |
Dr Reddy's Labs | 4307.25 | 2.30 | 0.05 | 13349.10 |
Sun Pharma.Inds. | 900.55 | -10.60 | -1.16 | 12803.21 |
Lupin | 600.75 | 10.45 | 1.77 | 11055.93 |
Apollo Hospitals | 3668.00 | 142.25 | 4.03 | 9153.00 |
Zydus Lifesci. | 372.85 | 6.60 | 1.80 | 7790.40 |
Glenmark Pharma. | 393.60 | 6.85 | 1.77 | 7567.93 |
Alkem Lab | 3024.35 | 56.70 | 1.91 | 7219.68 |
Divi's Lab. | 3449.15 | -69.55 | -1.98 | 6798.61 |
Torrent Pharma. | 2900.90 | 266.35 | 10.11 | 6450.83 |
Ipca Labs. | 917.15 | -20.85 | -2.22 | 5114.11 |
Alembic Pharma | 738.65 | -2.35 | -0.32 | 5051.44 |
Laurus Labs | 559.20 | 5.25 | 0.95 | 4768.72 |
Abbott India | 17698.85 | -369.45 | -2.04 | 4310.02 |
Gland Pharma | 2853.25 | 109.75 | 4.00 | 3462.88 |
Glaxosmi. Pharma | 1513.25 | -11.95 | -0.78 | 3193.74 |
Granules India | 258.60 | 4.45 | 1.75 | 3134.98 |
Sanofi India | 6534.80 | 31.30 | 0.48 | 2956.60 |
Ajanta Pharma | 1728.30 | 27.05 | 1.59 | 2718.59 |
Quick Links for Bajaj Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices